2024 Corazon's Charity of the Year
Corazon Health is delighted to announce that EACH (East Anglia's Children's Hospices) has been chosen as their 2024 Charity of The Year, following a selection process that included a vote by employees.
Optibrium launches a metabolism prediction software platform tailored to DMPK scientists
Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery
Pioneering cataract test for babies has worldwide potential
Researchers are calling on new parents to back a national study to help prevent the most common cause of preventable childhood blindness, congenital cataracts.
CRA Insights: A landscape assessment of newborn screening (NBS) in Europe
Newborn screening (NBS) has become an integral part of many public health programs.1 NBS programs have minimized pati
Jon Hume joins Cuttsy+Cuttsy as New Commercial Director
Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.
TR Events & Catering Announces George Nolan as New Head of Sales
TR Events & Catering, a leading multi-service event management provider in Cambridgeshire and Suffolk, is thrilled to announce the appointment of George Nolan as the new Head of Sales. This appointment is a significant milestone for the company, signalling its continued growth and evolution in the competitive event management industry.
Butterfly and moth genomes mostly unchanged despite 250 million years of evolution
Comparison of over 200 high-quality butterfly and moth genomes reveals key insights into their biology, evolution and diversification over the last 250 million years, as well as clues for conservation.
Challenges to a dual: What makes a dual-brand approach viable?
Pharmaceutical and biologic therapies are increasingly demonstrating their effectiveness in the treatment of multiple diseases.
SPT Labtech continues to support UKHSA genomics surveillance project to bolster global health security
Cambridge – SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, continues its partnership with the UK Health Security Agency (UKHSA)
Drug trial brings hope to Parkinson’s patients
Cambridge researchers and Addenbrooke’s Hospital patients are joining forces to trial a new drug aimed at treating Parkinson’s disease.
Launching evolue - hello World
Hello World We are excited to announce the official launch of evolue, a dynamic agile consultancy, that is committed to empowering organisations and individuals in navigating the ever-changing landscape of today's world. About Us:
MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space
Company’s synthetic affinity reagents are antibody alternatives designed to advance the speed, safety, and efficiency of manufacturing at scale, making advanced therapies more accessible to patients. Investment led by Mercia Ventures, with Calculus Capital and Angel investors als
New Business Weekly Award to honour a special Cambridge Tech Week champion
Tony Quested writes: Cambridge Tech Week, which made its bow in 2023, is being brought back for a second successive year from September 9-14 with a rammed programme highlighting game-changing innovation engendered in the Cluster and impacting the world.
CMR Surgical hires industry leader to drive operations across Asia Pacific, the Middle East and Africa
Sushobhan Dasgupta joins as President and Chief Commercial Officer for Asia Pacific, the Middle East and Africa.
New sponsorship rules to impact care providers and overseas care workers
From 11 March 2024, care providers in England will only be able to sponsor new overseas nationals if they are providing services regulated by the Care Quality Commission (CQC), says head of Stone King’s immigration team, Julie Moktadir.
Trust backs study to fight asbestos-related cancer
An Addenbrooke’s consultant clinical oncologist is part of an international team led by Queen Mary University of London to make a significant breakthrough in the treatment of a rare and hard-to-treat cancer.
Key genes linked to DNA damage and human disease uncovered
More than one hundred key genes linked to DNA damage have been uncovered through systematic screening of nearly 1,000 genetically modified mouse lines, in a new study published (14 February) in Nature.
Optibrium enables collaborative design in its StarDrop platform
The new Idea Tracker capability further improves the efficiency of drug discovery by supporting project management, idea sharing and molecule design tracking The software promotes collaboration within and across teams for more cohesive workflows
'I was only doing my job'. No-one has the right to obey
High Performance Change writes...Subordination doesn't justify abdication. A Post Office investigator's defence that 'I was only doing my job' isn't enough. Interestingly, the skills you need to be able to look yourself in the mirror happen to be the same ones that underpin your ability to adapt.
Cambridge Festival spotlights health events
World-first childhood health research programme, UK-first pre-eclampsia study, and debate on using stem cell-based embryos in research headline health events at Cambridge Festival 2024
impulse 2024 Programme – open for applications
The impulse 2024 programme is open for applications! The 12-week hybrid programme – which runs from 23 April to 12 July 2024 – is offered online and in-person via the Maxwell Centre, the University of Cambridge’s hub for industry and research.
Cambridge Science Centre welcomes new trustee to its Board
Harriet Fear, MBE, has recently joined the Cambridge Science Centre Board, bringing with her extensive expertise that complements the current Board's strengths, led by Dr David Cleevely.
Cambridge Festival 2024 unveils bumper programme
Fixing the NHS, stopping wars, and the effects of AI on the democratic process headline a packed programme of events at this year’s Cambridge Festival 2024.
A clearer vision for surgical robotics: CMR Surgical announces significant update to Versius
CMR Surgical (CMR) – the global surgical robotics business – has today announced the launch of vLimeLite – an integrated fluorescence imaging system to visualise ICG (Indocyanine green), which will give surgeons enhanced visualisation, where indicated.
